Delivery Order SPE2DE24D0021-SPE2D626F85L5
- Not listed
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,159.12 on November 4, 2025, for the provision of BinaxNow COVID antigen testing kits to support the Department of Defense Medical Supply Chain. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of November 12, 2025. Performance will be executed from Fisher Scientific's location in Pittsburgh, Pennsylvania. This award represents a...
- Fisher Scientific Company L.L.C. received a delivery order award on August 22, 2025, for the procurement of BinaxNOW COVID-19 antigen testing kits. The contract carries a ceiling value of $2,213.20 and is structured as a fixed-price agreement with economic price adjustment provisions. Funding originates from the Medical Supply Chain division within the Department of Defense. The place of performance is listed as Pittsburgh, PA. This delivery order represents a child contract, indicating it falls...
- Fisher Scientific Company L.L.C. was awarded a fixed-price delivery order valued at $5,822.94 on April 24, 2025, for the procurement of BinaxNOW COVID-19 antigen testing kits. The contract, which represents no set-aside designation, will be performed in Pittsburgh, Pennsylvania, with an ultimate completion date of May 1, 2025. This delivery order is structured with economic price adjustment provisions and is funded through the Medical Supply Chain, a defense-oriented federal agency. Fisher...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $2,205.00 for BinaxNow COVID-19 antigen OTC test kits (12 tests per 2-test case) by the Defense Medical Supply Chain federal agency. The contract, awarded on September 9, 2025, with an ultimate completion date of September 16, 2025, utilizes a fixed price with economic price adjustment pricing structure. The place of performance is Pittsburgh, Pennsylvania. This delivery order represents a child contract, indicating...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,076.64 on August 21, 2025, for the procurement of BinaxNow COVID-19 antigen testing kits. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and is funded by the Defense Department's Medical Supply Chain division. Performance will be completed in Pittsburgh, Pennsylvania, with an ultimate completion date of August 28, 2025. This award represents a child contract with no...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,322.00 for BinaxNOW COVID-19 antigen testing kits on April 30, 2025, with an ultimate completion date of May 7, 2025. This fixed-price contract with economic price adjustment was issued by the Medical Supply Chain, a defense-oriented federal agency, and will be performed in Pittsburgh, Pennsylvania. As a child contract, this delivery order is part of a larger contracting vehicle, leveraging Fisher Scientific's established...
- Fisher Scientific Company L.L.C. received a delivery order award valued at $1,339.82 from the Department of Defense's Medical Supply Chain on December 4, 2025, for BINAXNOW COVID-19 Antigen OTC test kits (12 tests per box, case quantity). This fixed-price delivery order with economic price adjustment is expected to be completed by December 11, 2025, and will be performed in Pittsburgh, Pennsylvania. The award was made without a set-aside designation, indicating open competition. This delivery...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,897.80 on August 11, 2025, for the provision of BinaxNOW COVID antigen testing kits to support the Medical Supply Chain, a defense-oriented federal agency. This fixed-price delivery order with economic price adjustment capability represents a child contract under a larger vehicle and will be performed in Pittsburgh, Pennsylvania, with an ultimate completion date of August 18, 2025. No set-aside designation was applied...
- Fisher Scientific Company L.L.C. received a delivery order award valued at $3,920 for BinaxNow COVID-19 test kits under a fixed-price contract with economic price adjustment. The order, issued on September 16, 2025, with an ultimate completion date of September 23, 2025, will be performed in Pittsburgh, Pennsylvania. This is a child contract with no set-aside designation, awarded through open competition to support the Medical Supply Chain, a defense-focused federal agency function. Fisher...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,176.00 by the Department of Defense's Medical Supply Chain on November 20, 2025, for BinaxNow COVID-19 antigen over-the-counter test kits (12 tests per case). This is a fixed-price contract with economic price adjustment provisions, with an ultimate completion date of November 28, 2025. The contract was competitively awarded with no set-aside designation and will be performed in Pittsburgh, Pennsylvania, where Fisher...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D626F85L5Delivery Order
Fisher Scientific Company L.L.C. has been awarded a $4.3K delivery order for BinaxNOW COVID-19 antigen testing kits under a fixed-price contract with economic price adjustment provisions. The award was issued on January 7, 2026, with an ultimate completion date of January 14, 2026, and will be performed in Pittsburgh, Pennsylvania. This delivery order was issued without a set-aside designation, indicating open competition, and is funded by the Department of Defense's Medical Supply Chain division. As a child contract, this award likely derives from a larger indefinite delivery vehicle or multiple award schedule arrangement, consistent with Fisher Scientific's established role as a critical federal supplier of laboratory equipment and medical diagnostic products. Fisher Scientific's selection reflects the company's extensive experience as a major federal vendor specializing in scientific products, laboratory equipment, and medical supplies. The company has maintained a substantial contract portfolio with the Department of Veterans Affairs and the Department of Defense, delivering specialized diagnostic equipment, laboratory reagents, and consumable supplies across multiple federal agencies. This COVID-19 testing kit procurement aligns with the company's core competencies in providing diagnostic solutions supporting federal healthcare operations and represents a continuation of Fisher Scientific's established supplier relationship with the federal government.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 1/6/26 |